Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The ongoing regulation of generic drugs.

× No keyword cloud information.

29 in total

1. Cost-effectiveness analysis in markets with high fixed costs.

Authors: David M Cutler; Keith M Marzilli Ericson
Journal: Pharmacoeconomics Date: 2010 Impact factor: 4.981

2. New approaches to rewarding pharmaceutical innovation.

Authors: Paul Grootendorst; Aidan Hollis; David K Levine; Thomas Pogge; Aled M Edwards
Journal: CMAJ Date: 2010-12-13 Impact factor: 8.262

3. [Generics in Austria 2003-2008: an update].

Authors: Markus Müller
Journal: Wien Klin Wochenschr Date: 2008 Impact factor: 1.704

Review 4. Reducing the cost of headache medication.

Authors: Glen D Solomon
Journal: Curr Pain Headache Rep Date: 2009-06

Review 5. Generics, chemisimilars and biosimilars: is clinical testing fit for purpose?

Authors: John B Warren
Journal: Br J Clin Pharmacol Date: 2013-01 Impact factor: 4.335

6. [Economic public health significance of generic drugs].

Authors: Doris Tschabitscher; Fabian Waechter; Marcus Müllner
Journal: Wien Klin Wochenschr Date: 2009 Impact factor: 1.704

7. Potential savings from an evidence-based consumer-oriented public education campaign on prescription drugs.

Authors: Julie M Donohue; Michael A Fischer; Haiden A Huskamp; Joel S Weissman
Journal: Health Serv Res Date: 2008-05-13 Impact factor: 3.402

8. The differences between the branded and generic medicines using solid dosage forms: In-vitro dissolution testing.

Authors: Mubarak Nasser Al Ameri; Nanda Nayuni; K G Anil Kumar; David Perrett; Arthur Tucker; Atholl Johnston
Journal: Results Pharma Sci Date: 2011-12-07

9. Competition in prescription drug markets: the roles of trademarks, advertising, and generic names.

Authors: Roger Feldman; Félix Lobo
Journal: Eur J Health Econ Date: 2012-07-20

10. Managed care and medicare use of generics: seizing the opportunity, part 2.

Authors: Gary M Owens
Journal: Am Health Drug Benefits Date: 2008-05